Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
RECRUITING
NCT05274048
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
18
Enrollment(s)
3
Study location(s)
INTERVENTIONAL (PHASE1)
Gastric Cancer
Gastrointestinal Cancer
HER2 Gene Mutation
ACTIVE_NOT_RECRUITING
NCT03334617
Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy
528
Enrollment(s)
45
Study location(s)
INTERVENTIONAL (PHASE2)
Non-Small Cell Lung Cancer
RECRUITING
NCT06533826
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
357
Enrollment(s)
11
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer
HER2-low Breast Cancer
Metastatic Breast Cancer
HER2-negative Breast Cancer
RECRUITING
NCT06271837
A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing Tumors
175
Enrollment(s)
31
Study location(s)
INTERVENTIONAL (PHASE2)
Advanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)
RECRUITING
NCT06750484
Trial of Trastuzumab Deruxtecan in Previously Treated HER2
40
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer Metastatic
ACTIVE_NOT_RECRUITING
NCT03529110
DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]
524
Enrollment(s)
164
Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer
NOT_YET_RECRUITING
NCT07217938
Novel Treatment of Radiation Associated Dysphagia With Statins
48
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Radiation-associated Dysphagia
Head &Amp; Neck Cancer
ACTIVE_NOT_RECRUITING
NCT04639219
A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations
102
Enrollment(s)
30
Study location(s)
INTERVENTIONAL (PHASE2)
Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
11
12
13
14
15